John DiPersio, MD, PhD, on Ongoing Advancements in Stem Cell Transplantation and Cell Therapy
The director of the Center for Gene and Cellular Immunotherapy at Washington University School of Medicine discussed novel innovations that lie on the horizon.
Dr. DiPersio on Investigational Targeted Cellular Therapies in AML
John F. DiPersio, MD, PhD, discusses the current state of CAR T-cell therapy, dual affinity re-targeting, bi-specific T-cell engagers, and antibody-drug conjugates for acute myeloid leukemia treatment.